Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Editas Medicine, Inc. | 65,559 | reported | 13 Feb 2023 | tx 7+219,610−7,935 |
| APPLIED GENETIC TECHNOLOGIES CORP | 33,277 | reported | 15 Aug 2020 | tx 13+541,000−8,723 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2023 | SALE | Editas Medicine, Inc. | 2,790 | 9.67 USD | |
| 15 Jun 2022 | SALE | Editas Medicine, Inc. | 5,145 | 10.06 USD | |
| 10 Feb 2022 | GRANT_AWARD | Editas Medicine, Inc. | 31,709 | 0.00 USD | |
| 10 Feb 2022 | GRANT_AWARD | Editas Medicine, Inc. | 93,398 | 0.00 USD | deriv |
| 22 Dec 2021 | GRANT_AWARD | Editas Medicine, Inc. | 9,084 | 0.00 USD | |
| 14 Jun 2021 | GRANT_AWARD | Editas Medicine, Inc. | 32,701 | 0.00 USD | |
| 14 Jun 2021 | GRANT_AWARD | Editas Medicine, Inc. | 52,718 | 0.00 USD | deriv |
| 15 Aug 2020 | TAX_WITHHOLDING | APPLIED GENETIC TECHNOLOGIES CORP | 5,723 | 5.77 USD | |
| 05 Aug 2020 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 50,000 | 0.00 USD | deriv |
| 15 Aug 2019 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 39,000 | 0.00 USD | |
| 15 Aug 2019 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 52,000 | 0.00 USD | deriv |
| 14 Dec 2018 | SALE | APPLIED GENETIC TECHNOLOGIES CORP | 3,000 | 3.35 USD | |
| 25 Jul 2018 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 85,000 | 0.00 USD | deriv |
| 17 Jul 2017 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 50,000 | 0.00 USD | deriv |
| 22 Sept 2016 | PURCHASE | APPLIED GENETIC TECHNOLOGIES CORP | 1,300 | 8.87 USD | |
| 22 Sept 2016 | PURCHASE | APPLIED GENETIC TECHNOLOGIES CORP | 1,700 | 8.87 USD | |
| 07 Jul 2016 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 50,000 | 0.00 USD | deriv |
| 21 Jul 2015 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 51,000 | 0.00 USD | deriv |
| 01 Jun 2015 | GRANT_AWARD | APPLIED GENETIC TECHNOLOGIES CORP | 110,000 | 0.00 USD | deriv |